Response to an experimental HBV vaccine permits withdrawal of HBIg prophylaxis in fulminant and selected chronic HBV-infected liver graft recipients

Liver Transplantation

Volumn 11, Issue 10, 2005, Pages 1228-1234

  Star̈kel, Peter ^a   Stoffel, Michel ^b   Lerut, Jan ^a   Horsmans, Yves ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b GLAXOSMITHKLINE BIOLOGICALS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOTRANSFERASE; ANTIVIRUS AGENT; AS 04; CYCLOSPORIN; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS B VACCINE; IMMUNOLOGICAL ADJUVANT; LAMIVUDINE; PHOSPHORYL LIPID A; TACROLIMUS; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; DRUG COST; DRUG DOSE REGIMEN; DRUG FORMULATION; ERYTHEMA; FEMALE; HEPATITIS B; HUMAN; IMMUNIZATION; INFECTION PREVENTION; INFLAMMATION; INJECTION PAIN; LIVER GRAFT; LIVER TRANSPLANTATION; MALE; POSTOPERATIVE INFECTION; PRIORITY JOURNAL; TREATMENT OUTCOME;

ADULT; AGED; CADAVER; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VACCINES; HEPATITIS B, CHRONIC; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULINS; LIVER TRANSPLANTATION; LIVING DONORS; MALE; MIDDLE AGED; RECOMBINANT PROTEINS; TISSUE DONORS; TREATMENT OUTCOME;

EID: 27244435932     PISSN: 15276465     EISSN: None     Source Type: Journal    
DOI: 10.1002/lt.20464     Document Type: Article

References (26)

1. Coloquhoun SD, Belle SH, Samuel D, Pruett TL, Teperman LW. Transplantation in the hepatitis B patient and current therapies to prevent recurrence. Semin Liver Dis 2000;20(Suppl 1):7-12.
2. Maddrey WC. Hepatitis B: an important public health issue. J Med Virol 2000;61:362-366.
3. Pruett T. Primary transplant treatment of hepatitis B: hepatitis B immunoglobulin (passive immunization). Liver Transpl Surg 1997;3(Suppl 1):S13-S15.
4. Kim WR, Poterucha JJ, Kremers WK, Ishitani MB, Dickson ER. Outcome of liver transplantation for hepatitis B in the United States. Liver Transpl 2004;10:968-974.
5. Samuel D, Muller R, Alexander G, Fassati L, Ducot B, Benhamou J-P, et al. Liver transplantation in European patients with hepatitis B surface antigen. Investigators of the European Concerted Action on Viral Hepatitis Study. N Engl J Med 1993;329: 1842-1847.
6. McGory RW, Ishitani MB, Oliveira WM, Stevenson WC, McCullough CS, Dickson RC, et al. Improved outcome of orthotopic liver transplantation for chronic hepatitis B cirrhosis with aggressive passive immunisation. Transplantation 1996;61: 1358-1364.
7. Terrault NA, Zhou S, Combs C, Hahn JA, Lake JR, Roberts JP, et al. Prophylaxis in liver transplant recipients using a fixed schedule of hepatitis B immunoglobulin. Hepatology 1996;24: 1327-1333.
8. Lerut JP, Donataccio M, Ciccarelli O, Roggen F, Jamart J, Laterre PF, et al. Liver transplantation and HbsAg-positive postnecrotic cirrhosis: adequate immunoprophylaxis and delta virus co-infection as the significant determinants of long-term prognosis. J Hepatol 1999;30:706-714.
9. Keefe EB. End-stage liver disease and liver transplantation: role of lamivudine therapy in patients with chronic hepatitis B. J Med Virol 2000;61:403-408.
10. Trautwein C. Mechanisms of hepatitis B virus graft reinfection and graft damage after liver transplantation. J Hepatol 2004;41: 362-369.
11. Villamil FG. Prophylaxis with anti-HBs immune globulins and nucleoside analogues after liver transplantation for HBV infection. J Hepatol 2003;39:466-474.
12. Sanchez-Fueyo A, Rimola A, Grande L, Costa J, Mas A, Navasa M, et al. Hepatitis B immunoglobulin discontinuation followed by hepatitis B virus vaccination: a new strategy in the prophylaxis of hepatitis B virus recurrence after liver transplantation. Hepatology 2000;31:496-501.
13. Angelico M, Di Paolo D, Trinito MO, Petrolati A, Araco A, Zazza S, et al. Failure of reinforced triple course of hepatitis B vaccination in patients transplanted for HBV-related cirrhosis. Hepatology 2002;35:176-181.
14. Albeniz Arbizu E, Barena Maruguan R, Oton Nieto E, Carrera Alonso E, Garcia Gonzalez M, Moreno Garcia J, et al. Prophylaxis of recurrent hepatitis B virus by vaccination after liver transplant: preliminary results. Transplant Proc 2003;35:1848-1849.
15. Bienzle U, Gunther M, Neuhaus R, Neuhaus P. Successful hepatitis B vaccination in patients who underwent transplantation for hepatitis B virus-related cirrhosis: preliminary results. Liver Transpl 2002;8:562-564.
16. Ishitani M, McGory R, Dickson R, Caldwell S, Bickston S, McCollough C, et al. Retransplantation of patients with severe posttransplant hepatitis B in the first allograft. Transplantation 1997;64:410-414.
17. Sawyer RG, McGory RW, Gaffey MJ, McCollough CC, Shepard BL, Houlgrave CW, et al. Improved clinical outcome with liver transplantation for hepatitis B-induced chronic liver failure using passive immunization. Ann Surg 1998;227:841-850.
18. Roche B, Feray C, Gigou M, Roque-Afonso AM, Arulnaden JL, Delvart V, et al. HBV DNA persistence 10 years after liver transplantation despite successful anti-HBs passive immunoprophylaxis. Hepatology 2003;38:86-95.
19. Loinaz C, de Juanes JR, Gonzales EM, Lopez A, Lumbreras C, Gomez R, et al. Hepatitis B vaccination results in 140 liver transplant recipients. Hepatogastroenterology 1997;44:235-238.
20. Stark K, Günther M, Schönfeld C, Tullius SG, Bienzle U. Immunizations in solid-organ transplant recipients. Lancet 2002;359:957-965.
21. Poland GA, Jacobson RM. Prevention of hepatitis B with hepatitis B vaccine. N Engl J Med 2004;351:2832-2838.
22. Bienzle U, Günther M, Neuhaus R, Vandepapeliere P, Vollmar J, Lun A, et al. Immunization with an adjuvant hepatitis B vaccine after liver transplantation for hepatitis B-related disease. Hepatology 2003;38:811-819.
23. Rosenau J, Hooman N, Rifai K, Solga T, Tilmann HL, Grezegowski E, et al. Active immunization after liver transplantation for HBV related liver disease: failure to induce HBV-specific Immoral and cellular immune responses [Abstract]. J Hepatol 2004;40(Suppl 1):6.
24. Levitz RE, Cooper BW, Regan HC. Immunization with high dose intradermal recombinant hepatitis B vaccine in health care workers who failed to respond to intramuscular vaccination. Infect Control Hosp Epidemiol 1995;16:88-91.
25. Choy BY, Malik Peiris JS, Chan TM, Lo SKF, Lui SL, Lai KN. Immunogenicity of intradermal hepatitis B vaccination in renal transplant recipients. Am J Transpl 2002;2:965-969.
26. Petrillo RP. Hepatitis B and renal transplantation: securing the sword of Damocles [Editorial]. Hepatology 2002;36:1041-1045.